首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.
【24h】

Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.

机译:人类乳头瘤病毒辅助因子通过疾病进展和人类乳头瘤病毒类型的研究来了解子宫颈癌的早期终点和决定因素。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Human papillomavirus (HPV) cofactors for cervical cancer include smoking, multiparity, and oral contraceptive use, but their mechanisms of action are not fully understood. It is also unknown whether cofactors vary by HPV genotypes. The Study to Understand Cervical Cancer Early Endpoints and Determinants (SUCCEED) is a cross-sectional study comprising women referred to the University of Oklahoma from November 2003 to September 2007 for abnormal cervical screening results. Detailed questionnaire data and liquid cytology specimens were collected and the latter was genotyped for HPV using the LINEAR ARRAY HPV Genotyping Test. The present analysis includes women with both questionnaire and HPV data and diagnosed with
机译:宫颈癌的人乳头瘤病毒(HPV)辅助因子包括吸烟,多胎和口服避孕药,但其作用机理尚未完全了解。还不知道辅因子是否因HPV基因型而异。理解宫颈癌早期终点和决定因素的研究(SUCCEED)是一项横断面研究,由2003年11月至2007年9月转诊至俄克拉荷马大学的妇女进行,以进行异常的子宫颈筛查结果。收集详细的调查表数据和液体细胞学标本,并使用线性阵列HPV基因分型测试对后者进行HPV基因分型。本分析包括具有问卷调查和HPV数据且被诊断为

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号